Brief: Tetratherix Says BioOptix Enters Agreement With Alcon Research
01/12/2025 01:38
Dec 1 (Reuters) - Tetratherix Ltd TTX.AX: BIOOPTIX ALCON UPDATE BIOOPTIX ENTERS AGREEMENT WITH ALCON RESEARCH ALCON TO PROVIDE MILESTONE-BASED DEVELOPMENT FUNDING TO COMPLETE RANGE OF SPECIFIC PRECLINICAL STUDIES Further company coverage: TTX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetratherix
See all newsBrief: Tetratherix Receives Substantive FDA Review Update For Tegenix 510(K) Submission
Australia's Tetratherix rises after FDA review update on Tegenix application
Brief: Tetratherix Receives Firm Commitments For A$15 Million Placement At Issue Price Of A$6
Brief: Tetratherix Requests Trading Halt
Australia's Tetratherix rises on nasal delivery deal of GLP-1 in US market